Physician profile
Morgan Kizzar
NPI 1912261074
$387.26
in general payments reported to CMS, 2019-2025
8 companies · $303 in 2025
The $303 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21.98 · 2020: $12.91 · 2022: $22.84 · 2024: $26.97 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $330.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alliance Medical | $123.08 | 2025 | |
| Depuy Synthes Sales INC. | $84.07 | 2019-2025 | Speed Triad, Motoband, Dynaforce |
| Organogenesis INC. | $80.70 | 2025 | Novachor, Apligraf |
| Convatec INC. | $26.97 | 2024 | |
| Orthofix Medical, INC. | $22.84 | 2022 | |
| Reprise Biomedical, INC. | $19.86 | 2025 | Miro3d |
| Vertex Pharmaceuticals Incorporated | $16.83 | 2025 | |
| Horizon Therapeutics Plc | $12.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Kizzar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.